DDF (Drug Delivery Formulation) focuses on bringing innovative solutions to the greatest challenges in pharmaceuticals, biologics and device development.

Lunch and learn roundtable discussion: One implantable platform, 10-year life. A new era in drug delivery.

Speakers:

• Ashley Hawson SVP, Innovation & Operations, Cambridge Consultants
• Elizabeth Proos VP, Product Development, Daré Bioscience, Inc.

In this presentation you will learn about a groundbreaking implantable drug delivery platform that is designed to deliver therapy for up to a decade, removing daily adherence burdens and connecting patients with care teams.

The presentation by Daré Bioscience and Cambridge Consultants will share patient impact, design milestones, and the integration of engineering, drug formulation, and connected health, highlighting how this first-of-its-kind platform could expand access and transform long-acting therapy.

No pills to forget to take.  No going to the clinic once a month for speciality injections. Turn it on/off remotely, and all the adherence data goes back to the clinician for monitoring.

Ashley Hawson

SVP, Innovation & Operations | View profile

Ashley leads the Healthcare and North America operations, overseeing a multidisciplinary team of more than 100 engineers, scientists, and designers who are pioneering advances in Class II and III medical devices, photonics, human–machine understanding, and regulated medical AI.